FLURISK project proposes a model to rank animal influenza strains by their potential to infect humans
The final report of the FLURISK project by the European Food Safety Authority (EFSA) proposes a risk assessment framework to rank animal influenza strains according to their potential to infect humans.
The final report of the FLURISK project by the European Food Safety Authority (EFSA) proposes a risk assessment framework to rank animal influenza strains according to their potential to infect humans. This model focuses on avian influenza viruses and, besides the characteristics of the virus strains, takes into account population data, animal production systems and geographic location of the viruses in question.
As an output, it provides an ‘opportunity’ map that indicates the global potential for a generic avian influenza virus to jump the species barrier from poultry to humans. The map thus provides information on high-risk areas for zoonotic infection from poultry. While the ultimate aim is to develop a risk assessment framework that can be used as a prioritisation tool for intervention against potentially pandemic virus strains circulating in animal populations, the report recognises that, at this point, “this model is a prototype and would require further development to truly be effective as a decision-making aid”.
It is proposed to proceed with a trial period that would allow to fine-tune the tool. In addition, the report identifies scientific gaps and areas for the future research.
Experts from the European Centre for Disease Prevention and Control have contributed to the FLURISK project in the capacity of external advisors.
World Health Organization recommendations for the influenza virus vaccine composition for the 2020 southern hemisphere season
11 Oct 2019 - On September 2019, WHO has agreed on the recommended composition of the quadrivalent and trivalent influenza vaccines for the southern hemisphere 2020 influenza season.
WHO recommendations for influenza virus vaccine composition for the 2019–2020 northern hemisphere season
1 Mar 2019 - On 18–20 February 2019, the World Health Organization (WHO) agreed on the recommended composition of the quadrivalent influenza vaccine for the northern hemisphere 2019–2020 influenza season: an A/Brisbane/02/2018 (H1N1)pdm09-like virus, an A(H3N2) virus component to be announced on 21 March 2019, a B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage) and a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage).
WHO recommendations for influenza virus vaccine composition for the 2018-2019 Northern hemisphere season
26 Feb 2018 - On 19-21 February 2018 the World Health Organization (WHO) agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2018-2019 influenza season.